Tumor Ablation Market Projected to Reach $2,079.2 million by 2031 | Medtronic, PLC., AngioDynamics Inc., Boston Scientific Corporation

Tumor Ablation Market is the focal point of DataM Intelligence's latest market research report, offering a comprehensive analysis of this dynamic sector. This in-depth study goes beyond a basic overview, exploring the intricate dynamics that shape the market. By examining regional trends, demand patterns, and potential breakthroughs, DataM Intelligence aims to empower businesses and stakeholders with valuable insights for navigating the evolving landscape. The insights from this report can illuminate pathways for informed decision-making and drive strategic growth in Tumor Ablation Market.

The Global Tumor Ablation Market reached US$ 797.4 million in 2022 and is projected to witness lucrative growth by reaching up to US$ 2,079.2 million by 2031. The global tumor ablation market is expected to exhibit a CAGR of 13.1% during the forecast period (2024-2031).

Will the Tumor Ablation Market become the sector's next big opportunity? To find out, delve into the analysis and projections for Tumor Ablation Market. This market research study offers in-depth insights into the opportunities, challenges, and trends currently shaping the machinery landscape, enabling industry participants to make informed decisions in a dynamic environment. Take advantage of the opportunity in the Tumor Ablation Market! (2031)

Get a Free Sample Research PDF - https://datamintelligence.com/download-sample/tumor-ablation-market

Tumor ablation is a minimally invasive medical procedure used to destroy cancerous or abnormal tissue, typically tumors, using extreme temperatures or chemicals. The process involves inserting a probe or needle directly into the tumor and applying energy sources such as heat (radiofrequency ablation), cold (cryoablation), or chemicals (chemical ablation) to eliminate the targeted cells. Tumor ablation is commonly used for treating tumors in the liver, kidneys, lungs, and bones, offering a less invasive alternative to traditional surgery with reduced recovery times and minimal damage to surrounding healthy tissue.

Key Growth Drivers in Tumor Ablation Market:

The Growing Adoption of Novel Technologies for Treating Hard-to-Treat Cancers is Propelling Global Tumor Ablation Market Growth

In 2022, Dr. Joseph Whitlark of Crozer Health successfully performed a minimally invasive procedure for a patient with metastatic cancer using a cutting-edge technology known as Aliya Pulsed Electric Field (PEF). Crozer Health is one of only seven healthcare facilities in the U.S. offering this advanced treatment, highlighting the increasing use of innovative techniques in the tumor ablation market.

DataM Intelligence profiles some of the most reputed organizations present in the Tumor Ablation market. They are as follows:

Medtronic, PLC., AngioDynamics Inc., Boston Scientific Corporation, Healthtronics, Inc., BVM Medical Limited, COMSOL Inc., Galil Medical, Inc., INTIO Inc., Misonix, Inc., NeuWave Medical, Inc., SonaCare Medical, LLC

Segment Covered in the Tumor Ablation Market:

By Technology: Radiofrequency (rf) Ablation, Microwave Ablation, Cryoablation, Other Technologies

By Application: Liver cancer, Lung cancer, Kidney cancer, Bone Metastasis, Others

By Treatment Mode: Surgical Ablation, Laparoscopic Ablation, Percutaneous Ablation

Regional Analysis:

The global Tumor Ablation Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa.

Key Developments

Imagin Medical, a Canada-based company specializing in urologic oncology, acquired the enCAGE Coil Precision Ablation System for Prostate Cancer from Belgium's TROD Medical NV in August 2022 for $2.5 million. This acquisition aims to strengthen Imagin Medical's presence in urologic oncology and expand its prostate cancer treatment portfolio.

In March 2023, AngioDynamics announced a new partnership with Minimax Medical for the international distribution of its product portfolio, including Minimax's Radiofrequency Ablation System for tumors and nodules. The agreement took effect on November 15, 2022, extending the global reach of Minimax's products.

In August 2022, Bioventus Inc., a leader in active healing innovations, received 510(k) clearance from the US FDA for its neXus SonaStar Elite (SSE) handpiece. Powered by the neXus Ultrasonic Surgical Aspirator System, the SSE handpiece utilizes a proprietary digital algorithm for enhanced versatility and control. The neXus system integrates both soft and hard tissue removal capabilities, operating at multiple frequencies, including the newly approved 36 kHz SonaStar Elite Handpiece.

Get this Premium Report: https://www.datamintelligence.com/buy-now-page?report=tumor-ablation-market

Regional Analysis:

The global Tumor Ablation Market report focuses on six major regions: North America, South America, Europe, Asia Pacific, the Middle East, and Africa. The report offers detailed insight into new product launches, new technology evolutions, innovative services, and ongoing R&D. The report discusses a qualitative and quantitative market analysis, including PEST analysis, SWOT analysis, and Porter's five force analysis. The Tumor Ablation Market report also provides fundamental details such as raw material sources, distribution networks, methodologies, production capacities, industry supply chain, and product specifications.

Points Covered:

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Tumor Ablation market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Tumor Ablation Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The global Tumor Ablation market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Tumor Ablation Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Get Customization in the report as per your requierments: https://datamintelligence.com/customize/tumor-ablation-market

FAQ's

Q.1. What are the primary drivers of the Tumor Ablation Industry?

Q.2. What are the main factors propelling and impeding the growth of the Tumor Ablation market?

Q.3. What are the general structure, risks, and opportunities of the market?

Q.4. How do the prices, revenue, and sales of the leading Tumor Ablation market firms compare?

Q.5. What are the main segments of the market and how is it divided up?

Q.6. Which companies dominate the market, and what percentage of the market do they control?

Q.7. What trends are influencing the Tumor Ablation market now and in the future?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.